| Primary |
| Hypertension |
21.7% |
| Dementia |
8.7% |
| Heart Failure |
8.7% |
| Prostatic Disorder |
8.7% |
| Anxiety |
4.3% |
| Blood Potassium Decreased |
4.3% |
| Blood Pressure Abnormal |
4.3% |
| Cardiac Disorder |
4.3% |
| Diabetes Mellitus |
4.3% |
| Hypokalaemia |
4.3% |
| Hypokalemia |
4.3% |
| Memory Impairment |
4.3% |
| Muscle Spasms |
4.3% |
| Nervous System Disorder |
4.3% |
| Urine Flow Decreased |
4.3% |
| Vitamin D Decreased |
4.3% |
|
| Medication Error |
16.7% |
| Product Quality Issue |
16.7% |
| Balance Disorder |
8.3% |
| Muscle Spasms |
8.3% |
| Nausea |
8.3% |
| Renal Failure |
8.3% |
| Thirst |
8.3% |
| Unresponsive To Stimuli |
8.3% |
| Vomiting |
8.3% |
| Wrong Drug Administered |
8.3% |
|
| Secondary |
| Product Used For Unknown Indication |
22.5% |
| Hypertension |
12.8% |
| Neoplasm Malignant |
8.3% |
| Anxiety |
6.4% |
| Depression |
5.7% |
| Bipolar Disorder |
4.2% |
| Schizophrenia |
4.2% |
| Transient Ischaemic Attack |
4.2% |
| Oedema Peripheral |
3.6% |
| Blood Pressure Abnormal |
3.5% |
| Drug Use For Unknown Indication |
3.5% |
| Pain |
3.5% |
| Pneumonia Aspiration |
3.1% |
| Mineral Supplementation |
2.8% |
| Atrial Fibrillation |
2.6% |
| Pain In Extremity |
2.1% |
| Hypokalaemia |
1.9% |
| Electrolyte Substitution Therapy |
1.7% |
| Multiple Allergies |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
|
| Weight Increased |
22.0% |
| Vomiting |
8.5% |
| Hyperkalaemia |
4.9% |
| Hypokalaemia |
4.9% |
| Hypotension |
4.9% |
| Pain In Extremity |
4.9% |
| Renal Failure Acute |
4.9% |
| Weight Decreased |
4.9% |
| Completed Suicide |
3.7% |
| Drug Hypersensitivity |
3.7% |
| Heart Rate Irregular |
3.7% |
| Loss Of Consciousness |
3.7% |
| Suicide Attempt |
3.7% |
| Toxic Epidermal Necrolysis |
3.7% |
| Toxicity To Various Agents |
3.7% |
| Vertigo |
3.7% |
| Wrong Technique In Drug Usage Process |
3.7% |
| Abdominal Discomfort |
2.4% |
| Balance Disorder |
2.4% |
| Blood Potassium Increased |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
44.0% |
| Drug Use For Unknown Indication |
9.3% |
| Hypertension |
7.9% |
| Pain |
4.1% |
| Atrial Fibrillation |
3.2% |
| Rheumatoid Arthritis |
3.1% |
| Blood Cholesterol Increased |
2.6% |
| Depression |
2.6% |
| Crohn's Disease |
2.4% |
| Diabetes Mellitus |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Cardiac Disorder |
1.9% |
| Supplementation Therapy |
1.8% |
| Osteoporosis |
1.8% |
| Anxiety |
1.8% |
| Prophylaxis |
1.7% |
| Mineral Supplementation |
1.6% |
| Multiple Myeloma |
1.5% |
| Asthma |
1.5% |
|
| Weight Decreased |
11.7% |
| Vomiting |
10.9% |
| Weight Increased |
8.9% |
| Death |
6.7% |
| Drug Ineffective |
5.9% |
| Nausea |
5.5% |
| Pain |
4.9% |
| Pneumonia |
4.4% |
| Dyspnoea |
4.3% |
| Flushing |
3.8% |
| Oedema Peripheral |
3.6% |
| Urinary Tract Infection |
3.6% |
| Pain In Extremity |
3.5% |
| Vision Blurred |
3.5% |
| Rash |
3.4% |
| Tremor |
3.4% |
| Injection Site Pain |
3.1% |
| Pruritus |
3.1% |
| Headache |
2.9% |
| Diarrhoea |
2.8% |
|
| Interacting |
| Product Used For Unknown Indication |
36.4% |
| Hypertension |
11.4% |
| Diabetes Mellitus |
6.8% |
| Convulsion |
4.5% |
| Erectile Dysfunction |
4.5% |
| Gastrooesophageal Reflux Disease |
4.5% |
| Hypertonic Bladder |
4.5% |
| Plasma Cell Myeloma |
4.5% |
| Bipolar Disorder |
2.3% |
| Cardiac Disorder |
2.3% |
| Cardiac Failure Congestive |
2.3% |
| Diuretic Therapy |
2.3% |
| Gastrointestinal Disorder |
2.3% |
| Gout |
2.3% |
| Grand Mal Convulsion |
2.3% |
| Respiratory Disorder |
2.3% |
| Thyroid Disorder |
2.3% |
| Weight Decreased |
2.3% |
|
| Drug Interaction |
38.5% |
| Drug Level Decreased |
15.4% |
| Cardio-respiratory Arrest |
7.7% |
| Hyperkalaemia |
7.7% |
| Hypertension |
7.7% |
| Myocardial Infarction |
7.7% |
| No Adverse Event |
7.7% |
| Weight Decreased |
7.7% |
|
